CYTH实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	28 089.00
平均成交量	100 379
市值	36.18M
EPS	$0 ( 2024-03-18 )
下一个收益日期	( $0 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.020
ATR14	$0.0120 (0.95%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Sieger Markus	Buy	14 004	Common Stock
2024-02-13	Ostronic Francis Patrick	Buy	8 703	Common Stock
2024-02-13	Toig Randall M.	Buy	7 516	Common Stock
2024-02-13	Strattan Ce Rick	Buy	6 963	Common Stock
2024-02-13	Wong Vivien	Buy	6 330	Common Stock

INSIDER POWER
50.71
Last 99 transactions
Buy: 16 269 213 \| Sell: 5 479 045

音量相关性

長: 0.19 (neutral)

短: 0.15 (neutral)

Signal:(37.758) Neutral

Cyclo Therapeutics, Inc. 相关性

10 最正相关
STRO	0.944
ASPU	0.94
LSXMK	0.922
LSXMA	0.922
PRTG	0.917
NAKD	0.917
BOCH	0.915
SIRI	0.911
ACRX	0.91
BFRI	0.91

10 最负相关
PAE	-0.928
RMRM	-0.927
APOP	-0.916
PESI	-0.907
EBSB	-0.905
INTA	-0.905
LMNR	-0.905
NCAC	-0.903
NVDA	-0.903
FTNT	-0.902

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Cyclo Therapeutics, Inc. 相关性 - 货币/商品

-0.33
( neutral )

-0.01
( neutral )

0.00
( neutral )

Cyclo Therapeutics, Inc. 财务报表

Annual	2023
营收:	$1.08M
毛利润:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2023
营收:	$1.08M
毛利润:	$-2.41M (-223.91 %)
EPS:	$-1.230

FY	2022
营收:	$1.38M
毛利润:	$1.24M (89.90 %)
EPS:	$-1.810

FY	2021
营收:	$1.59M
毛利润:	$1.43M (90.16 %)
EPS:	$-2.24

Financial Reports:

No articles found.

Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.